Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma (NCT00893490)Shahid Beheshti University of Medical Sciences
Comparison of Two Different Medications Used to Treat Elevated Intracranial Pressure (NCT00359697)Thomas Jefferson University
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC (NCT00000999)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma (NCT00002262)University of California, San Francisco
Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia (NCT00005107)National Center for Research Resources (NCRR)
Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT® Grafted With Poly Sodium Styrene Sulfonate (NCT01454271)Societe ACTIVBIOMAT
A Study of Tecogalan Sodium (NCT00002342)Daiichi Pharmaceuticals
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells (NCT00000822)National Institute of Allergy and Infectious Diseases (NIAID)
Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment (NCT00012519)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules (NCT00001043)National Institute of Allergy and Infectious Diseases (NIAID)
Effects of Chocolate on Coronary Vasomotion in Patients After Heart Transplantation (NCT00521573)University of Zurich
Hypoxia Impairs Endothelial Function in HAPEs (NCT00176007)Heidelberg University
A Study to Assess Injection Comfort of Two Formulations of ATX-101 (NCT01320761)Kythera Biopharmaceuticals
Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients (NCT00000821)National Institute of Allergy and Infectious Diseases (NIAID)
Mentored Patient-Oriented Research Career Development Award (NCT00203684)University of California, Los Angeles
Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD) (NCT00318162)Hadassah Medical Organization
Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites (NCT00000111)National Center for Research Resources (NCRR)
Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies (NCT00081536)Aronex Pharmaceuticals
A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease (NCT00000696)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus (NCT02950688)National Institute of Allergy and Infectious Diseases (NIAID)
The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema (NCT00893854)Shahid Beheshti University of Medical Sciences
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis (NCT00004736)National Institute of Allergy and Infectious Diseases (NIAID)
Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052 (NCT00091416)National Institute of Allergy and Infectious Diseases (NIAID)
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects (NCT02434835)Kissei Pharmaceutical Co., Ltd.
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules (NCT00001076)National Institute of Allergy and Infectious Diseases (NIAID)
Prevention of Liver Damage During Liver Surgery (NCT00845689)Ludwig-Maximilians - University of Munich
A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia (NCT00089869)Eli Lilly and Company
Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults (NCT00073216)National Institute of Allergy and Infectious Diseases (NIAID)
Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults (NCT00111605)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease (NCT00002337)Otsuka America Pharmaceutical
Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours (NCT01194193)AstraZeneca
AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS (NCT00396968)Genzyme, a Sanofi Company
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients (NCT00002373)Glaxo Wellcome
Study Assessing Safety and Efficacy of B-cure Laser Treating Diabetic Chronic Wounds (NCT01493895)Hadassah Medical Organization
Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects (NCT00944177)Torrent Pharmaceuticals Limited
The Efficacy and Safety of Electronic Stimulation in Patients Who Underwent Reconstruction of the Anterior Cruciate Ligament (NCT00312793)Hadassah Medical Organization
A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects (NCT01567683)Moberg Pharma AB
Hyaluronic Acid Injection Post Arthroscopy - Does it Improve Immediate Function? Double Blind Controlled Prospective Study (NCT01442571)Hadassah Medical Organization
Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea (NCT00002121)VA Medical Center-Gainesville
A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain (NCT00410878)Alza Corporation, DE, USA
The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients (NCT00002326)Gilead Sciences
Insulin Loaded Orally Dissolved Films (Insulin-ODF) (NCT01446120)Hadassah Medical Organization
A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC (NCT00000753)National Institute of Allergy and Infectious Diseases (NIAID)
Health and Psychological Outcomes of Lifestyle Versus Traditional Physical Activity (NCT00281385)University of Alberta
A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 (NCT02193217)Tanabe Pharma Corporation
Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens (NCT00001091)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells (NCT00000667)National Institute of Allergy and Infectious Diseases (NIAID)
Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure (NCT00344734)Regional Hospital Holstebro
Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers (NCT00098163)National Institute of Allergy and Infectious Diseases (NIAID)
The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children (NCT00002380)Hoffmann-La Roche
Psychostimulant Abuse - Novel Treatment Approaches - 1 (NCT00000325)National Institute on Drug Abuse (NIDA)
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery (NCT00635245)Pfizer
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) (NCT00627835)British Columbia Cancer Agency
The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure (NCT00004854)National Center for Research Resources (NCRR)
A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. (NCT00365001)Hoffmann-La Roche
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults. (NCT00001044)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals (NCT00000633)National Institute of Allergy and Infectious Diseases (NIAID)
A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers (NCT00002261)Bristol-Myers Squibb
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3 (NCT00000756)National Institute of Allergy and Infectious Diseases (NIAID)
Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines (NCT00056745)National Institute of Allergy and Infectious Diseases (NIAID)
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. (NCT00000764)National Institute of Allergy and Infectious Diseases (NIAID)
The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients (NCT00002363)Columbia Research Laboratories
Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients (NCT00000906)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir (NCT00001133)National Institute of Allergy and Infectious Diseases (NIAID)
High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome (NCT00139308)Groupe Hospitalier Pitie-Salpetriere
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma (NCT00000660)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease (NCT00000881)National Institute of Allergy and Infectious Diseases (NIAID)
SCH708980 With and Without AmBisome for Visceral Leishmaniasis (NCT01437020)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia (NCT00000705)National Institute of Allergy and Infectious Diseases (NIAID)
The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy (NCT01168375)Shahid Beheshti University of Medical Sciences
Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls (NCT00345150)Regional Hospital Holstebro
Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa (NCT01927835)National Institute of Allergy and Infectious Diseases (NIAID)
Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM® (NCT01320410)Rovi Pharmaceuticals Laboratories
The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient (NCT00000661)National Institute of Allergy and Infectious Diseases (NIAID)
Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study (NCT01376765)National Institute of Allergy and Infectious Diseases (NIAID)
Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients (NCT00002098)AJI Pharma USA
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC (NCT00000735)National Institute of Allergy and Infectious Diseases (NIAID)
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection (NCT00001036)National Institute of Allergy and Infectious Diseases (NIAID)
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 (NCT00000358)National Institute on Drug Abuse (NIDA)
Atorvastatin in Myeloma (NCT00164086)Bayside Health
Bio-availability of a New Liquid Tumeric Extract (NCT00542711)Hadassah Medical Organization
Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines (NCT00008853)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children (NCT00000876)National Institute of Allergy and Infectious Diseases (NIAID)
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease (NCT00000814)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fed Conditions (NCT01798940)Torrent Pharmaceuticals Limited
The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients (NCT00002327)Gilead Sciences
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns (NCT00000642)National Institute of Allergy and Infectious Diseases (NIAID)
A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer. (NCT00034502)Eli Lilly and Company
A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients (NCT00002107)Chiron Corporation
Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants (NCT00002164)Agouron Pharmaceuticals
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir (NCT00000970)National Institute of Allergy and Infectious Diseases (NIAID)
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT00080028)Pharmacyclics LLC.
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy Subjects (NCT01400789)Wockhardt
New Method for Distal Interlocking of Cannulated Intramedullary Nails (NCT00648479)Hadassah Medical Organization
A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole (NCT00001027)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel (NCT00028132)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems (NCT00001015)National Institute of Allergy and Infectious Diseases (NIAID)
Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children (NCT00001118)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules (NCT00000957)National Institute of Allergy and Infectious Diseases (NIAID)
Photodynamic Therapy for Permanent Hair Removal (NCT00371930)University of Jena
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.